Evidence map›Paper›PMID 39346821›Full record

ArticleACS omega2024

Binding of Inhibitors to Nuclear Localization Signal Peptide from Venezuelan Equine Encephalitis Virus Capsid Protein Explored with All-Atom Replica Exchange Molecular Dynamics.

Bryan M Delfing, Xavier E Laracuente, Xingyu Luo, Audrey Olson, William Jeffries, Kenneth W Foreman, Mikell Paige, Kylene Kehn-Hall, Christopher Lockhart, Dmitri K Klimov

Abstract read
In one paragraph

Article in ACS omega, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Bryan M DelfingSchool of Systems Biology, George Mason University, Manassas, Virginia 20110, United States.
Xavier E LaracuenteSchool of Systems Biology, George Mason University, Manassas, Virginia 20110, United States.
Xingyu LuoSchool of Systems Biology, George Mason University, Manassas, Virginia 20110, United States.
Audrey OlsonSchool of Systems Biology, George Mason University, Manassas, Virginia 20110, United States.
William JeffriesSchool of Systems Biology, George Mason University, Manassas, Virginia 20110, United States.
Kenneth W ForemanDepartment of Chemistry and Biochemistry, George Mason University, Fairfax, Virginia 22030, United States.ORCID https://orcid.org/0000-0002-4908-6576
Mikell PaigeDepartment of Chemistry and Biochemistry, George Mason University, Fairfax, Virginia 22030, United States.
Kylene Kehn-HallDepartment of Biomedical Sciences and Pathobiology, Virginia-Maryland College of Veterinary Medicine, Virginia Polytechnic Institute and State University, Blacksburg, Virginia 24061, United States.
Christopher LockhartSchool of Systems Biology, George Mason University, Manassas, Virginia 20110, United States.ORCID https://orcid.org/0000-0001-7137-2088
Dmitri K KlimovSchool of Systems Biology, George Mason University, Manassas, Virginia 20110, United States.ORCID https://orcid.org/0000-0002-2893-867X

Funding

Developing capsid-importin alpha inhibitors for the treatment of VEEV infectionR01AI143817 · NIAID · GEORGE MASON UNIVERSITY · PI KEHN-HALL, KYLENE, KLIMOV, DMITRI KONSTANTINOVICH · 2020 to 2024
$3.6M
NIAID NIH HHS R01 AI143817
6 · The paper itself

Abstract

Several small molecule inhibitors have been designed to block binding of the Venezuelan equine encephalitis virus (VEEV) nuclear localization signal (NLS) sequence to the importin-α nuclear transport protein. To probe the inhibition mechanism on a molecular level, we used all-atom explicit water replica exchange molecular dynamics to study the binding of two inhibitors, I1 and I2, to the coreNLS peptide, representing the core fragment of the VEEV NLS sequence. Our objective was to evaluate the possibility of masking wherein binding of these inhibitors to the coreNLS occurs prior to its binding to importin-α. We found that the free energy of I1 and I2 binding to the coreNLS is less favorable than that to importin-α. This outcome argues against preemptive inhibitor binding to the coreNLS prior to importin-α. Instead, both inhibitors are expected to compete with the coreNLS peptide for binding to importin-α. The two factors responsible for the low affinities of the inhibitors to the coreNLS peptide are (i) the low cooperativity of binding to the peptide and (ii) the strong hydrophobic effect associated with binding to importin-α. Our results further show that upon binding to the coreNLS peptide, the inhibitors form multiple diverse binding poses. The coreNLS peptide coincubated with I1 and I2 adopts several conformational states, including open and collapsed, which underscores the fluidity of the coreNLS conformational ensemble as a target for inhibitors. Taken together with our prior investigations, this study sheds light on the molecular mechanism by which I1 and I2 ligands inhibit binding of the VEEV capsid protein to importin-α.

Identifiers

PMID39346821
PMCPMC11425950

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.